LRRK2 kinase in Parkinson's disease
Missouri S&T Magazine, Special Edition 1995 by Missouri S&T Library and Learning Resources
Lee Kimball (@LRK2) / X
Molecules, Free Full-Text
Cells, Free Full-Text
Parkinson's disease kinase LRRK2 coordinates a cell-intrinsic itaconate-dependent defence pathway against intracellular Salmonella
Parkinson-causing mutations in LRRK2 impair the physiological tetramerization of endogenous α-synuclein in human neurons
Frontiers LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's
Mitochondrial Calcium Dysregulation Contributes to Dendrite Degeneration Mediated by PD/LBD-Associated LRRK2 Mutants
Neurite Collapse and Altered ER Ca2+ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation - ScienceDirect
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity